Send Message
View as an RSS Feed
  • Eli Lilly (LLY) may have jumped 5.3% yesterday and added $3B to its market cap following news that its Solanezumab drug helped slow the progress of Alzheimer's Disease in Phase III trials, but SA author Brian Wilson points out that "the results were not statistically significant." This means that the study can't be used for an NDA submission of solanezumab, which is therefore "not going to make it"  [View news story]
    so now 12/12 they will do another trial
    Dec 12, 2012. 10:24 AM | Likes Like |Link to Comment
  • Why Eli Lilly Is Worth Every Penny  [View article]
    absolutely right
    Dec 11, 2012. 05:39 PM | 1 Like Like |Link to Comment
  • Down sizably earlier, the dollar moves back to near unchanged vs. the yen as chatter about QE (pick a number) in Japan crosses the Reuters wire. Sources are talking about a ¥5-¥10T boost in the BOJ's asset purchase program. FXY flat.  [View news story]
    it would appear that the yen needs to go lower to 85 thru 90 over time
    Dec 10, 2012. 03:51 PM | Likes Like |Link to Comment
  • Shinzo Abe - the frontrunner to be next Japanese PM - backs off recent calls to essentially make the BOJ an arm of the government, saying he would not comment on monetary policy as PM. His retreat comes as he was criticized by the country's main business lobby for actions threatening the credibility of JGBs.  [View news story]
    Dec 2, 2012. 03:40 AM | Likes Like |Link to Comment
  • The yen takes another header overnight, carving out a new multi-month low as opposition party head Shinzo Abe again calls for all necessary measures to bring inflation up to 2%. His comments came after core CPI came in flat Y/Y in October. The dollar +0.7% vs. the yen at ¥82.70. The Nikkei, +0.5%, continues to rise. Hopefully overseas owners of stocks are currency hedged[View news story]
    the yen has to decline for japanese exporters to be competitive
    Dec 2, 2012. 03:40 AM | Likes Like |Link to Comment
  • Eli Lilly (LLY) intends to expand in China, which, says CEO John Lechleiter, "will soon be the second-largest pharmaceutical market in the world." Over 260M Chinese suffer from chronic diseases while healthcare coverage has been expanded to 95% of the population. However, Eli Lilly faces major obstacles, including very slow regulatory approval and poor IP protection.  [View news story]
    great move for lilly
    Dec 2, 2012. 03:40 AM | Likes Like |Link to Comment
  • Continued jawboning by Shinzo Abe - the man who looks to be the next Japanese PM - fails to do a lot for the yen. Amidst a weak retail sales report, he again calls for unlimited monetary easing and says the BOJ governor must be held accountable if a 2% inflation target (not yet official policy) isn't hit. The dollar is up a hair on the yen, buying ¥82.13.  [View news story]
    conventional wisdom is that the yen will go to 85 over the next 6 months and possibly 90 within a year--i agree at this time
    Nov 30, 2012. 02:57 AM | Likes Like |Link to Comment
  • Selling in the yen picks up steam, the currency hitting a 7-month low vs. the dollar as a wider-than-expected trade deficit - led by sorry export numbers - is likely to add fuel to the (possibly) incoming government's call to remove the BOJ's independence. The dollar +0.8% vs the yen, and buying ¥82.34. The Nikkei doesn't complain, +0.9%[View news story]
    go yen
    Nov 21, 2012. 10:40 AM | Likes Like |Link to Comment
  • "The moment is here," writes Goldman's Jim O'Neill, joining others who say it's finally happening - the yen is entering a sustained weakening phase. Along with noting a change in the tone of leadership, O'Neill points out an end to Japan's vaunted trade surpluses has caused the current account to go into deficit.  [View news story]
    sounds right to me
    Nov 19, 2012. 10:15 AM | Likes Like |Link to Comment
  • The BOJ could be a more aggressive buyer of JGBs (monetization?) only if the government makes a "legal promise" to improve the country's balance sheet, says Nobuo Inaba, maybe in line to be next BOJ governor. The comments are a bit at odds with supposed next PM Shinzo Abe's call for "unlimited easing." The dollar falls vs. the yen, -0.2% and buying ¥81.15.  [View news story]
    obviously inaba won't be the next boj governor
    Nov 19, 2012. 10:13 AM | Likes Like |Link to Comment
  • "It is only monetization when the market tells us it is monetization," says a BOJ member. In other words, if central banks hoover up government debt and yields go down, it's not monetization. Wonderful logic. Kyle Bass again takes central bankers to task for actions surely to end in a massive loss of wealth and earnings power. A bear on Japan's finances for some time, he's never been comfortable just shorting the yen ... until now. (see also[View news story]
    bass has been wrong on the yen for years
    Nov 19, 2012. 10:12 AM | Likes Like |Link to Comment
  • Lilly: The Worst Play In Big Pharma?  [View article]
    i believe lilly will succeed with their alzheimer drug and clearly the article's comments on competing drugs are nonsense as someone else has commented. also lilly has cancer and arthiritis drugs coming along shortly.
    Nov 18, 2012. 02:58 PM | Likes Like |Link to Comment
  • Tokyo bucks the selloff, +1.9% as opposition party leader Shinzo Abe - possibly set to come to power in coming elections - makes clear his position: "The biggest economic problem is prolonged deflation and a strong yen ... Markets will only start to react once unlimited monetary easing is conducted." The dollar rises to a 6-month high, +1.2% and buying ¥81.17. EWJ +1.6% premarket, but also consider funds which hedge against the yen.  [View news story]
    hopefully the yen will weaken over time--japan has been crippled by an overvalued yen for the last two years. plus the swiss have recently
    implemented "unlimited easing" successfully. if the swiss have done it, obviously the same approach is a "no brainer" for japan at this time.
    Nov 18, 2012. 06:49 AM | Likes Like |Link to Comment